Saturday 17 October 2026
Export ICUI’s income statement to Excel — free account
ICU Medical, Inc.
ICUI Healthcare Medical Instruments & Supplies
ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 46.9%, free cash flow grew 656.0% and total debt fell 7.96%, each against the same quarter a year earlier.
162.99
4.24
−2.54%
Follow ICUI
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
39.15 | 59.42 | 161.71 | 38.11 | 51.68 | 48.74 | 0.00 | 0.00 | 0.00 | 7,133.50 |
Piotroski F-Score |
7 | 5 | 5 | 4 | 4 | 7 | 1 | 6 | 5 | 6 |
P/S ratio |
6.27 | 3.28 | 3.35 | 3.05 | 3.53 | 3.82 | 1.67 | 1.08 | 1.59 | 1.58 |
Altman Z-Score |
34.95 | 10.42 | 10.74 | 9.35 | 12.33 | 13.53 | 1.86 | 1.63 | 2.10 | 2.12 |
P/FCF ratio |
34.66 | 56.71 | 63.98 | 0.00 | 34.89 | 26.97 | 0.00 | 33.06 | 33.03 | 38.68 |
Altman Z″-Score (non-manufacturers) |
23.67 | 8.30 | 8.33 | 8.86 | 10.60 | 11.32 | 2.52 | 2.73 | 2.91 | 2.90 |
Beneish M-Score |
(2.64) | (0.13) | (3.18) | (2.09) | (3.13) | (3.04) | (1.74) | (2.97) | (2.81) | (2.65) |
P/Operating CF |
112.08 | 50.13 | 93.79 | 79.00 | 57.11 | 60.92 | (2,229.31) | 26.81 | 94.16 | 58.01 |
P/B ratio |
3.61 | 3.54 | 3.71 | 2.80 | 2.99 | 3.11 | 1.83 | 1.15 | 1.93 | 1.66 |
Price to Tangible BV |
3.76 | 4.07 | 4.18 | 3.40 | 3.53 | 3.64 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
5.10 | 3.10 | 3.13 | 2.85 | 3.25 | 3.43 | 2.30 | 1.69 | 2.12 | 2.01 |
EV/EBITDA |
18.72 | 75.12 | 41.74 | 19.51 | 22.38 | 21.10 | 23.28 | 14.79 | 18.79 | 17.99 |
EV/Operating CF |
21.51 | 25.99 | 27.31 | 35.36 | 18.52 | 16.86 | (84.58) | 22.99 | 24.79 | 24.98 |
EV/FCF |
28.18 | 53.70 | 59.78 | (881.26) | 32.10 | 24.18 | (32.75) | 51.62 | 44.15 | 49.42 |
Quick Ratio |
12.37 | 2.43 | 2.24 | 1.99 | 2.74 | 3.35 | 0.88 | 0.86 | 0.88 | 0.98 |
Current Ratio |
14.04 | 4.11 | 3.72 | 3.55 | 4.71 | 5.13 | 2.50 | 2.53 | 2.59 | 2.39 |
Net Debt/EBITDA |
(4.31) | (5.62) | (3.64) | (1.39) | (1.95) | (2.44) | 6.38 | 5.32 | 4.73 | 3.91 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 2.13% | 2.95% | 2.45% | 36.61% | 37.20% | 37.65% | 31.72% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 | 0.79 | 0.77 | 0.81 | 0.60 |
Asset Turnover |
0.57 | 1.17 | 0.91 | 0.77 | 0.74 | 0.72 | 0.71 | 0.51 | 0.56 | 0.54 |
Operating CF/Net income |
1.43 | 2.25 | 5.56 | 1.01 | 2.56 | 2.59 | 0.84 | (5.60) | (1.73) | 245.69 |
Capex/Depreciation |
(1.04) | (1.19) | (1.16) | (1.37) | (1.09) | (0.89) | (0.37) | (0.39) | (0.40) | (0.43) |
Interest Coverage |
702.89 | (6.49) | 41.97 | 195.56 | (51.02) | (62.18) | (0.65) | 0.24 | 0.45 | 0.52 |
| 10.17% | 7.39% | 2.34% | 7.65% | 6.03% | 6.61% | (4.01%) | (1.41%) | (5.76%) | 0.04% | |
| 9.48% | 6.24% | 1.87% | 6.16% | 5.03% | 5.66% | (2.32%) | (0.67%) | (2.74%) | 0.02% | |
ROIC |
24.10% | (0.93%) | 2.11% | 5.99% | 5.37% | 7.04% | (0.76%) | 0.41% | 0.83% | 0.86% |
Return on Tangible Assets |
10.27% | 6.52% | 2.59% | 9.27% | 7.29% | 7.95% | (5.40%) | (2.19%) | (8.86%) | 0.06% |
Average Days of Receivables |
54.03 | 59.72 | 45.96 | 58.29 | 35.64 | 29.36 | 35.49 | 26.10 | 28.01 | 29.53 |
Research and Development Expense of Revenue |
3.41% | 3.97% | 3.78% | 3.84% | 3.38% | 3.61% | 4.08% | 3.78% | 3.72% | 3.92% |
Selling, General and Administrative Expense of Revenue |
23.57% | 23.38% | 22.86% | 21.87% | 22.34% | 22.99% | 26.68% | 26.86% | 26.82% | 28.02% |
Intangible Assets out of Total Assets |
0.04 | 0.10 | 0.09 | 0.14 | 0.13 | 0.12 | 0.54 | 0.54 | 0.52 | 0.53 |
Share Based Compensation of Revenue |
4.02% | 1.50% | 1.73% | 1.73% | 1.88% | 2.08% | 1.58% | 1.80% | 1.97% | 2.50% |
Graham Net Nets |
0.22 | 0.13 | 0.13 | 0.15 | 0.15 | 0.15 | (0.31) | (0.42) | (0.21) | (0.21) |
Graham Number |
58.77 | 70.70 | 44.49 | 85.88 | 81.91 | 91.38 | 0.00 | 0.00 | 0.00 | 6.23 |
Earnings Yield |
2.55% | 1.68% | 0.62% | 2.62% | 1.93% | 2.05% | (1.95%) | (1.21%) | (3.11%) | 0.01% |
Free Cash Flow Yield |
2.88% | 1.76% | 1.56% | (0.11%) | 2.87% | 3.71% | (4.21%) | 3.03% | 3.03% | 2.59% |
Revenue per Share |
23.46 | 65.90 | 68.65 | 61.38 | 60.79 | 62.07 | 95.53 | 93.77 | 97.67 | 90.55 |
Operating CF per Share |
5.56 | 7.87 | 7.86 | 4.94 | 10.65 | 12.62 | (2.60) | 6.90 | 8.37 | 7.30 |
Capex per Share |
(1.32) | (4.06) | (4.27) | (5.14) | (4.51) | (3.82) | (4.12) | (3.83) | (3.67) | (3.61) |
Free Cash Flow per Share |
4.25 | 3.81 | 3.59 | (0.20) | 6.15 | 8.80 | (6.72) | 3.07 | 4.70 | 3.69 |
Cash per Share |
27.53 | 15.30 | 18.74 | 14.19 | 19.65 | 26.75 | 8.92 | 10.57 | 12.65 | 12.50 |
Shareholders Equity per Share |
40.83 | 61.09 | 61.96 | 66.76 | 71.85 | 76.21 | 87.56 | 88.14 | 80.58 | 86.19 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
40.83 | 61.09 | 61.96 | 66.76 | 71.85 | 76.21 | 87.56 | 88.14 | 80.58 | 86.19 |
Free Cash Flow |
68.66 | 74.74 | 73.20 | (4.09) | 128.54 | 186.59 | (160.47) | 74.03 | 114.57 | 90.89 |
Working Capital |
528.56 | 654.37 | 677.75 | 633.73 | 725.29 | 829.03 | 740.64 | 739.43 | 885.80 | 691.69 |
Capital Expenditures |
(21.28) | (79.68) | (87.01) | (106.01) | (94.21) | (80.95) | (98.34) | (92.17) | (89.46) | (88.96) |
Net Current Asset Value |
524.56 | 565.97 | 605.30 | 567.06 | 659.35 | 765.11 | (1,190.52) | (1,033.76) | (796.71) | (736.13) |
EV/EBIT |
23.33 | 0.00 | 147.06 | 33.56 | 42.03 | 36.61 | 0.00 | 167.41 | 117.74 | 104.88 |
Capex to Sales |
0.06 | 0.06 | 0.06 | 0.08 | 0.07 | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 |
Price to Operating Income |
28.69 | 0.00 | 157.38 | 35.95 | 45.68 | 40.84 | 0.00 | 107.21 | 88.08 | 82.08 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.24 | 0.17 | 0.17 | 0.17 | 0.18 | 0.19 | 0.42 | 0.38 | 0.51 | 0.46 |
Cash ROIC |
6.21% | 4.99% | 4.45% | (0.24%) | 6.54% | 8.37% | (4.06%) | 1.85% | 2.97% | 2.45% |
Accounts Receivable Turnover |
6.66 | 9.66 | 7.22 | 6.69 | 7.79 | 11.45 | 13.92 | 11.79 | 13.83 | 12.28 |
Accounts Payable Turnover |
12.57 | 18.66 | 8.35 | 6.38 | 8.08 | 10.78 | 10.65 | 8.30 | 10.45 | 9.32 |
Inventory Turnover |
3.83 | 5.13 | 2.77 | 2.45 | 2.48 | 2.73 | 3.21 | 2.16 | 2.41 | 2.35 |
Average Days of Payables |
30.03 | 32.95 | 52.98 | 59.10 | 32.40 | 35.90 | 49.81 | 36.04 | 34.69 | 39.98 |
Days of Inventory on Hand |
101.03 | 121.59 | 136.83 | 155.15 | 142.00 | 128.44 | 160.56 | 170.42 | 137.04 | 159.51 |
Average Receivables |
57.00 | 133.83 | 193.90 | 189.26 | 163.16 | 114.99 | 163.81 | 191.64 | 172.20 | 181.67 |
Average Payables |
14.16 | 46.43 | 99.35 | 124.55 | 100.25 | 76.50 | 148.52 | 182.97 | 149.03 | 151.20 |
Average Inventory |
46.45 | 168.96 | 299.91 | 324.40 | 326.28 | 302.58 | 493.12 | 702.68 | 647.02 | 600.27 |
Average Assets |
665.76 | 1,100.82 | 1,541.17 | 1,638.89 | 1,728.04 | 1,822.21 | 3,198.19 | 4,447.04 | 4,291.19 | 4,127.22 |
Average Common Equity |
620.01 | 929.20 | 1,230.95 | 1,320.45 | 1,439.75 | 1,559.15 | 1,852.98 | 2,106.67 | 2,044.32 | 2,044.53 |
Columns are period end dates